PMS13 Comparative Budget Impact of Teriparatide Versus Parathormone 1-84 Using Indirect Comparison Efficacy Data in Italy

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.1368
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Comparing the Values of Intact Parathormone and 1– 84 PTH to Predict Hyperparathyroidism in Hemodialysis Patients

Journal of Nephropathology
Nephrology
2017English

Pmu30 - Budget and Health Impact of Immuno-Oncology Treatments in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn21 - Comparative Efficacy of Nivolumab±ipilimumab Versus Standard of Care (Soc) for Third-Line (3l) Patients With Recurrent Small Cell Lung Cancer (Sclc) Using Population-Adjusted Indirect Comparison

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Budget Impact Analysis of Apixaban to Treat and Prevent Venous Thromboembolism in Italy

Farmeconomia. Health economics and therapeutic pathways
2016English

Efficacy and Safety of Infliximab Versus Adalimumab in the Therapy of Fistulizing Crohn Disease: A Systematic Review and Indirect Comparison

2020English

Abaloparatide Versus Teriparatide: A Head to Head Comparison of Effects on Fracture Healing in Mouse Models

Acta Orthopaedica
MedicineSurgeryOrthopedicsSports Medicine
2018English

Pmd36 - Budget Impact Analysis of the Use of Lurasidone in Patients With Schizophrenia in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

SAT0480 Comparative Effectiveness of Secukinumab and Infliximab in Psoriatic Arthritis Assessed by Matching-Adjusted Indirect Comparison Using Pivotal Phase 3 Clinical Trial Data

2017English

Comparative Efficacy of Combination Immunotherapy and Targeted Therapy in the Treatment of BRAF-mutant Advanced Melanoma: A Matching-Adjusted Indirect Comparison

Immunotherapy
OncologyAllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy